I can only see them signing a global deal with an equal profit...

I can only see them signing a global deal with an equal profit sharing agreement + upfront costs of 150-200 million. This is not a lot for a potential partner to stump up for a shot at the OA market and would be fair considering the risks still at play. While this may not sound like a lot, it's still a multi-billion dollar deal subject to certain milestones being achieved. I cannot envision a regional partner being OK with funding global trials, yet only being able to benefit from a specific geographical area. On the flip-side, if PAR were to go it alone and wait for a readout from the P3 trials, then I think they would be able to negotiate a better deal.